HMGB1 promotes lymphangiogenesis of human lymphatic endothelial cells in vitro (Q39616677)

13 September 2017

HMGB1 promotes lymphangiogenesis of human lymphatic endothelial cells in vitro (English)

1 reference

13 September 2017

0 references

1 reference

Yuanyuan Qiu

1

1 reference

13 September 2017

Ying Chen

2

1 reference

13 September 2017

Xin Fu

3

1 reference

13 September 2017

Lei Zhang

4

1 reference

13 September 2017

Jing Tian

5

1 reference

13 September 2017

Quan Hao

6

1 reference

13 September 2017

22 December 2010

1 reference

13 September 2017

1 reference

13 September 2017

29

1 reference

13 September 2017

358-363

1 reference

13 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-010-9778-7

13 September 2017

0 references

cites work

Lymphangiogenesis and cancer metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Molecular targeting of lymphatics for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Hepatocyte growth factor promotes lymphatic vessel formation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Dose-dependent response of FGF-2 for lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Adipokine resistin promotes in vitro angiogenesis of human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Characterization of cDNA sequences corresponding to three distinct HMG-1 mRNA species in line CHO Chinese hamster cells and cell cycle expression of the HMG-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

High-mobility group protein 1(Y): metastasis-associated or metastasis-inducing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

HMGB1: a two-headed signal regulating tumor progression and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Molecular characterization of the canine HMGB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9778-7

Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer

21 January 2018

1 reference

12 December 2020

Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer

1 reference

12 December 2020

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

12 December 2020

HMGB1 attenuates anti-metastatic defense of the lymph nodes in colorectal cancer

1 reference

12 December 2020

[Expression and clinical significance of HMGB1 and RAGE in cervical squamous cell carcinoma].

1 reference

12 December 2020

Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma

1 reference

12 December 2020

High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma

1 reference

12 December 2020

Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics

1 reference

12 December 2020

10.1007/S12032-010-9778-7

Identifiers

DOI

1 reference

13 September 2017

1 reference